WHO Sounds Concern Over Acute Shortage of Obesity Injections

Less than 10% of people that would benefit from weight-loss injections like Wegovy can access them, warns the global health agency as it releases its inaugural recommendations on the therapies.

With in excess of 1,000,000,000 individuals worldwide currently obese, it is advocating for more widespread and fairer access to these injectable treatments.

According to estimates, in excess of 2,000,000,000 could be living with obesity by 2030 if no action is taken.

"The latest guidance recognises that obesity is a chronic disease that can be treated with thorough and lifelong care," remarked its chief Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and logistical bottlenecks are significant barriers to broad availability to the injections that can assist patients in reducing considerable weight, explains the agency.

GLP-1 Therapy Supply Crisis

Even in the present best projected outlook, the supply of GLP-1 therapies might only reach around 100 million people – under 10% of the global need, as stated by the health organization.

The recommendation encourages countries and companies to increase availability, via approaches including voluntary licensing.

A patent on a key compound – the main ingredient of Novo Nordisk's Wegovy – is set to lapse in several countries in 2026.

The Way Weight-Loss Drugs Function

The injections mimick a biological compound to slow digestion, suppress the appetite and increase satiety so people consume fewer calories.

People commonly see weight reduction within a few weeks of commencing the weekly injections.

Evidence indicates people may regain a significant portion within a year of discontinuing the drug, when their usual hunger come back.

Being overweight or obese elevates your risk for contracting health problems, including diabetes, heart disease, brain attack, and specific cancers.

Excess weight concerns people in all nations and was responsible for millions of fatalities worldwide in 2024, according to the health agency.